Ratings
0
Nobody has rated this yet. Be the first!
Works
4
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Association of maternal prenatal smoking GFI1-locus and cardio-metabolic phenotypes in 18,212 adults
Amyotrophic lateral sclerosis
